Systematic Review and External Validation of Prediction Models Based on Symptoms and Biomarkers for Identifying Endoscopic Activity in Crohn's Disease
Year: 2019
Type: review
Authors: Eelco C. Brand, Sjoerd G. Elias, Itta M. Minderhoud, Julius J. van der Veen, Filip J. Baert, David Laharie, Peter Bossuyt, Yoram Bouhnik, Anthony Buisson, Guy Lambrecht, Edouard Louis, Benjamin Pariente, Marieke J. Pierik, C. Janneke van der Woude, Geert R.A. M. D’Haens, Séverine Vermeire, Bas Oldenburg
Institutions: Utrecht University, University Medical Center Utrecht, Tergooi, AZ Delta, Centre Hospitalier Universitaire de Bordeaux, Imelda Hospital, Hôpital Beaujon, Assistance Publique – Hôpitaux de Paris, Université Paris Diderot, Damiaan Dicht bij het leven, Centre Hospitalier Universitaire de Liège, Hôpital Claude Huriez, Maastricht University Medical Centre, Erasmus MC, Amsterdam University Medical Centers, University of Amsterdam, Universitair Ziekenhuis Leuven
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Amgen, Eli Lilly and Company, Pfizer, AstraZeneca, Merck, Roche, Sanofi, Gilead Sciences, Biogen, Celgene, AbbVie, Meso Scale Diagnostics, Takeda Pharmaceutical Company, Ablynx, Hospira, Celltrion, Shire, Ferring Pharmaceuticals, Vifor Pharma, Ipsen, Norgine, Genentech, Samsung, Allergan, Sandoz, Janssen Pharmaceuticals
OpenAlex ID: W2998025834